1. Selective serotonin reuptake inhibitors confirmed as treatment for depressionIn treating depression, a 6 to 9 month course of selective serotonin reuptake inhibitors following initial recovery after a first episode of depression is confirmed by this study. This systematic review, based on six classic long-term randomized controlled trials, supports current clinical practice guidelines.
Popularity: unranked [?]
Related posts:
- Can We Identify Depressed Patients Who Are Not Going To Respond To Drug Treatment?
- Penn Collaboration Suggest Antidepressants May Change Personality, Leading To Reduced Depression
- HIV-Positive People With Depression More Likely To Follow Treatment Regimens When Taking SSRIs, Study Finds
- HIV-Positive People With Depression More Likely To Follow Treatment Regimens When Taking SSRIs, Study Finds
- Doctors Must Look After Their Health Too – British Medical Journal
Comments
No Responses to “News From The Canadian Medical Association Journal”